NNC6989-0001

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC6989-0001, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity [Phase 1]

See pricing